CA Patent

CA2717326C — Preparation of lenalidomide

Assigned to Dr Reddys Laboratories Ltd · Expires 2018-10-23 · 8y expired

What this patent protects

Processes for the preparation of substantially pure lenalidomide. The application also relates to an enriched, sub-stantially pure, and pure amorphous form of lenalidomide and solid dispersions containing amorphous lenalidomide.

USPTO Abstract

Processes for the preparation of substantially pure lenalidomide. The application also relates to an enriched, sub-stantially pure, and pure amorphous form of lenalidomide and solid dispersions containing amorphous lenalidomide.

Drugs covered by this patent

Patent Metadata

Patent number
CA2717326C
Jurisdiction
CA
Classification
—
Expires
2018-10-23
Drug substance claim
No
Drug product claim
No
Assignee
Dr Reddys Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.